13F Portfolios

Saturn V Capital Management LP: IMMIX BIOPHARMA INC (IMMX): Quarterly 13F Position History

As of Q1 2026, Saturn V Capital Management LP reported 3,693,585 shares of IMMIX BIOPHARMA INC (IMMX), worth $33.6M and representing 6.1% of its 13F equity book. Quarter-over-quarter share count change: + 694,416 (+23.2%) . The position first appeared in Q4 2025 and has been disclosed across 2 13F-HR filings in Pactolio's tracked window.

Recent initiation: Saturn V Capital Management LP first reported IMMX on the Q4 2025 filing — fewer than three quarters of history are available.

Quarterly 13F-HR Disclosure History Source: SEC 13F-HR filings, 2 quarter s

Quarter Shares QoQ Share Change Share Change (%) Market Value Weight Implied Price
Q1 2026 3,693,585 +694,416 +23.2% $33.6M 6.1% $9.1
Q4 2025 2,999,169 $15.7M 2.9% $5.2

Methodology & FAQ

How This Position History Is Sourced

Each row is one SEC Form 13F-HR filing disclosing this position. Share count, market value, and reported quarter are taken verbatim from the filing; portfolio weight is recomputed against the same filing's total reported equity book. Implied price-per-share is market value divided by shares — a quarter-end mark, not the manager's cost basis. See the full methodology document for the normalization rules.

When did Saturn V Capital Management LP first disclose a IMMX position in 13F-HR filings?

Saturn V Capital Management LP first reported IMMIX BIOPHARMA INC (IMMX) on its 13F-HR filing for the period ending 2025-12-31 (Q4 2025). The position has appeared on 2 reported quarters within Pactolio's tracked window.

What was Saturn V Capital Management LP's most recent quarter-over-quarter share-count change in IMMX?

Between Q4 2025 and Q1 2026, Saturn V Capital Management LP added 694,416 shares of IMMX (+23.2%), bringing the total reported position to 3,693,585 shares at a market value of $33.6M.

Does the implied price-per-share represent Saturn V Capital Management LP's cost basis in IMMX?

No. The implied price-per-share column is the 13F-HR reported market value divided by reported share count on the filing date (end of quarter). It is a quarter-end mark, not a cost basis or transaction price. Use it as a sanity check on the value column, not as an indicator of the manager's entry or exit price.